Promoter holding
64.27%
EP
Emcure Pharmaceuticals Limited - Due diligence report
A 360° intelligence report on Emcure: trust score, financial health, credit view, compliance, directors, growth and distress signals - gener…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Emcure — 360° Intelligence Report
Generated from MCA filings & public records88/100
Trust Score
Low Risk
Emcure is assessed as Low Risk with a Trust Score of 88/100. Emcure is an active public limited indian non-government company incorporated in 1981, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.
Report generated on 11 Nov 2026 from the latest processed filings. Emcure Pharmaceuticals Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
88/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
72/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
95/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
80/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Consolidated · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 95/100 Low Risk
- Liabilities ≈ 38% EBITDA - serviceable.
- Moderate gearing (D/E 1.42).
- Working-capital cover adequate.
- Profitable - internal accruals available.
- Externally credit-rated (A).
Charges position: 19 open (1,655.61 cr) · 114 satisfied (7,259.14 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Others | 42 | 48.0 cr |
| Axis Bank Limited | 29 | 48.0 cr |
| Citicorp International Limited | 1 | 48.0 cr |
| State Bank Of India | 5 | 48.0 cr |
| Yes Bank Limited | 1 | 48.0 cr |
| Tata Capital Financial Services Limited | 3 | 48.0 cr |
Compliance Score: 72/100 Moderate
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2026).
- Litigation present in 3 court forum(s).
- Delayed payments to MSME suppliers disclosed (176 disclosure(s)).
- 21 active GST registration(s).
Legal cases on record (3)
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| SHAILESH KRIPALU AYYANGAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SATISH RAMANLAL MEHTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VIJAY KESHAV GOKHALE | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| BERJIS MINOO DESAI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Chetan Rajendra Sharma | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| TAJUDDIN SABIR SHAIKH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SATISH RAMANLAL MEHTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SAMIT SATISH MEHTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SUNIL RAJANIKANT MEHTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| MUKUND KESHAO GURJAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VIDYA RAJIV YERAVDEKAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PALAMADAI SUNDARARAJAN JAYAKUMAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| NAMITA VIKAS THAPAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| CHINNADHARAVARAM SUNDARESAN MURALIDHARAN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Chetan Sharma | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 15 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2025 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
2
Group entities
2
Capital events
2 allotment(s) · 9 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| EMCUTIX BIOPHARMACEUTICALS LIMITED | Subsidiary Company | 74.00% |
| EMCURE PHARMA UK LTD | Subsidiary Company | 74.00% |
| EMCURE PHARMACEUTICALS PTY LTD | Subsidiary Company | 74.00% |
| GENNOVA BIOPHARMACEUTICALS LIMITED | Subsidiary Company | 74.00% |
| ZUVENTUS HEALTHCARE LIMITED | Subsidiary Company | 74.00% |
Key managerial personnel: SATISH RAMANLAL MEHTA (CEO) · TAJUDDIN SABIR SHAIKH (CFO) · SATISH RAMANLAL MEHTA (Managing Director) · SAMIT SATISH MEHTA (Whole-time director) · SUNIL RAJANIKANT MEHTA (Whole-time director) · MUKUND KESHAO GURJAR (Whole-time director) · NAMITA VIKAS THAPAR (Whole-time director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 80 · Distress 90
Growth signals & trust indicators
Steady revenue growth: +2.1x over 4 year(s).
Profit expanded 24% year-on-year.
Net margin improved to 0.86.
EPFO headcount growing - hiring signal.
Operating for 45+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
19 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 2.54 cr.
3 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence82/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- No distress signals on file.
- Financial filings available for verification.
Banker assessment89/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 19 open charge(s) of 1,655.61 cr already registered.
- Compliance record supports lending.
Investor view87/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 4 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events17 Jun 2026
Charge created
Axis Bank Limited - 187.00 cr
15 May 2026
Charge satisfied
Axis Bank Limited
18 Apr 2026
Charge satisfied
Axis Bank Limited
17 Apr 2026
Charge satisfied
Hdfc Bank Limited
01 Apr 2026
Director appointed
CHINNADHARAVARAM SUNDARESAN MURALIDHARAN (Director)
31 Mar 2026
Latest balance sheet
Filed with ROC
12 Feb 2026
Charge satisfied
Others
11 Feb 2026
Charge satisfied
Axis Bank Limited
18 Dec 2025
Charge created
Citi Bank N.A. - 150.00 cr
19 Sep 2025
Charge created
Others - 100.00 cr
28 Aug 2025
Last AGM held
Annual general meeting
12 Jun 2025
Charge created
Others - 250.00 cr
27 Mar 2025
Charge satisfied
Hdfc Bank Limited
28 Jan 2025
Charge satisfied
Others
22 Jan 2025
Charge satisfied
Tata Capital Financial Services Limited
10
Key Observations
Auto-generated from the data aboveRevenue grew 61% over the last 4 financial year(s).
Net profit margin moved from 38% to 1.42.
Debt-to-equity stands at 2.1x - manageable leverage.
Net worth is positive.
15 active director(s) / partner(s); board looks stable and experienced.
21 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 2 subsidiary(ies) - assess on a consolidated basis.
Carries an external credit rating of A from Care.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
118 overseas direct investment(s) (ODI) on record - international footprint.
| Company | CIN | Location |
|---|---|---|
| Pcblltd | L23109WB1960PLC024602 | Kolkata, West Bengal, India |
| Gujarat Narmada Valley Fertilizers & Chemicals | L24110GJ1976PLC002903 | Na, Gujarat, India |
| Aarti Industries | L24110GJ1984PLC007301 | Vapi, Gujarat, India |
| Piramal Pharma | L24297MH2020PLC338592 | Mumbai, Maharashtra, India |
| The Ramco Cements | L26941TN1957PLC003566 | Rajapalayam, Tamil Nadu, India |
| Ipca Laboratories | L24239MH1949PLC007837 | Kandivali West, Maharashtra, India |
| Dabur | L24230DL1975PLC007908 | New Delhi, Delhi, India |
| Sudarshan | L24119PN1951PLC008409 | Pune, Maharashtra, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Emcure before audits and certifications: compliance score 72/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Emcure: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 95/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 80/100, margin trends, ownership structure and peer set for Emcure - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 88/100, distress signals and MSME payment-delay disclosures - know whether Emcure pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (3 case(s) on record), regulatory flags, charge documents trail and director networks for Emcure - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Emcure an active company?
Emcure has MCA status “Active” with a compliance score of 72/100 (Moderate).
Is Emcure financially healthy?
Emcure has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.
Should I do business with Emcure?
Its overall Trust Score is 88/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Emcure?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 15 active director(s) are on record.
Does Emcure have loans or charges against its assets?
19 open charge(s) are registered against its assets, and 114 earlier charge(s) stand satisfied.
Is Emcure up to date with its ROC filings?
Annual filings current (balance sheet Mar 2026). Overall compliance score: 72/100 (Moderate).
Is it risky to lend to Emcure?
Its Credit Risk Score is 95/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
